Industry Background:
Allergen extract is a mixture of various naturally occurring compounds such as allergens, proteins and other enzymes that are obtained from allergic sources including pollen, animal hair, molds, and insects. Naturally occurring compounds are used to test antibody response when exposed to various allergens and other immunotherapeutic tests. Furthermore, less popular diagnostic tests available in the market include allergen patch tests and allergen skin tests. Allergen patch tests are also referred to as Thin-Layer Rapid Use Epicutaneous Patch tests (T.R.U.E test).
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
High Growth Market | Asia Pacific |
Unit | Value (USD Million) |
Key Companies Profiled | ALK-Abello (Denmark), Allergopharma (Merck) (United States), Genentech (United States), Roche (Switzerland), Shionogi & Co. (Japan), Novartis (Switzerland) and HollisterStier Allergy (United States) |
This growth is primarily driven by The Rising demand for Immunotherapeutic Diagnosis and Treatment of Different Diseases Caused by Allergens and The High Demand for Oral Administration Allergen Extracts Over Subcutaneous Administration Allergen Extracts.
Globally, a noticeable market trend is evident High Demand due to Use in Diagnosis and Treatment of Allergic Rhinitis (hay fever) The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as ALK-Abello (Denmark), Allergopharma (Merck) (United States), Genentech (United States), Roche (Switzerland), Shionogi & Co. (Japan), Novartis (Switzerland) and HollisterStier Allergy (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail a competitive advantage through combined collaborations.
Key Developments in the Market:
On 1st October 2018, Roche has announced the U.S. Food and Drug Administration (FDA) has approved 75 mg/0.5 mL and 150 mg/1 mL single-dose prefilled syringes (PFS) for Xolair® (omalizumab) as an additional formulation for both allergic asthma and chronic idiopathic urticaria (CIU) indications. The new Xolair PFS formulation is expected to be available by the end of this year for the first time in the U.S. Xolair is currently available in a 150 mg single-dose vial with lyophilized, sterile powder for reconstitution.
Influencing Trend:
High Demand due to Use in Diagnosis and Treatment of Allergic Rhinitis (hay fever)
Market Growth Drivers:
The Rising demand for Immunotherapeutic Diagnosis and Treatment of Different Diseases Caused by Allergens and The High Demand for Oral Administration Allergen Extracts Over Subcutaneous Administration Allergen Extracts
Challenges:
Stringent Government Regulations
Restraints:
Side Effects Regarding Allergen Extract
Opportunities:
High Adoption due to Launch of New Sublingual Allergy Extract Therapies and Increasing Health care Expenditure in Developing Countries
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Allergen Extract Market
- Analysis about New Entrants in Allergen Extract Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators
Against this Challenging Backdrop, Allergen Extract Study Sheds Light on
The Allergen Extract Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Allergen Extract industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Allergen Extract industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.